🤚🏻 Five for Friday - Happy Holidays
Home / Blog / [wpbb post:title]
As 2022 comes to a close, the Foundation celebrates the significant progress this year brought us. After accepting poor outcomes for far too long, the Foundation welcomed a new standard of care – the first in the last decade. The Durvalumab approval is a big step forward and a significant change in the trajectory of the treatment options available to this community. We hope this approval energizes the rare cancer community to never give up hope for advances and treatments.
The work of the Foundation is only possible with your generous support. Thank you for helping to build this community. We wish you a happy, healthy, peaceful, and safe Christmas and New Year.
Feliz Navidad
圣诞节快乐
С Рождеством
메리 크리스마스
メリークリスマス
Get the most out of this email by contributing your ideas, feedback or questions to Allison Deragon at allison.deragon@cholangiocarcinoma.org.